Skip to main content
TipRanks
Go Ultimate75% OFF

Alnylam Pharma (ALNY) Q1 2024 Earnings Report

0 Followers

MX:ALNY Q1 2024 EPS Results

Actual EPS
-MXN 9.65
Consensus EPS
-MXN 20.71
Beat/Miss
Beat by +MXN 11.06
One Year Ago EPS
-MXN 25.98

MX:ALNY Q1 2024 Revenue Results

Actual Revenue
MXN 9.17B
Expected Revenue
MXN 7.94B
Beat/Miss
Beat by +MXN 1.23B
YoY Revenue Growth
+54.82%

Earnings Announcement Details

Quarter
Q1 2024
Date
05/02/2024
Time
Before Open
Conference Call
Thursday, May 2, 2024
MX:ALNY Upcoming Earnings

Alnylam Pharma's next earnings date is estimated for February 18, 2027, based on past reporting schedules.

Q1 2024 Earnings Call Audio

MX:ALNY Q1 2024 Earnings Call
0:00 / 0:00

Q1 2024 Earnings Slide Deck

Q1 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

MX:ALNY Earnings History

MX:ALNY earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 18, 20272026 (Q4)31.94-15.22――
Oct 29, 20262026 (Q3)30.80291.7134.14754.35% (+257.57)
Jul 30, 20262026 (Q2)30.2522.45-9.46337.25% (+31.92)
Apr 30, 20262026 (Q1)16.1828.02-8.16443.18% (+36.19)
Feb 12, 20262025 (Q4)21.3415.22-12.06226.15% (+27.28)
Oct 30, 20252025 (Q3)10.4134.14-16.14311.49% (+50.29)
Jul 31, 20252025 (Q2)-10.09-9.46-2.41-292.31% (-7.05)
May 01, 20252025 (Q1)-16.52-8.16-9.6515.38% (+1.48)
Feb 13, 20252024 (Q4)-10.99-12.06-20.4140.91% (+8.35)
Oct 31, 20242024 (Q3)-17.02-16.1421.34-175.65% (-37.48)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed